Activarti

Activarti is a biotechnology company focused on the discovery and development of novel small molecule therapeutics targeting G protein-coupled receptors (GPCRs). The company leverages a proprietary drug discovery platform designed to identify highly selective modulators for challenging GPCR targets involved in metabolic, inflammatory, and neurological conditions. By utilizing advanced structural biology and computational modeling, Activarti aims to overcome traditional limitations in GPCR drug design, such as off-target effects and poor bioavailability. The company's current pipeline is in the early stages of development, with several lead optimization programs underway. Activarti operates as a private entity, seeking to advance its internal programs while exploring strategic partnerships with larger pharmaceutical organizations.